Protocol ID |
Official Title |
Principal Investigator |
Lead CRC |
Disease Site |
Phase |
|
PRT811-01 ClinicalTrials.gov # |
A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of PRT811 in Subjects with Advanced Solid Tumors, CNS Lymphoma, and Recurrent High-Grade Gliomas | Dr. Allan Krutchik | Joanne Huff | Gliomas | I |
